Abivax to Attend Multiple Fall Investor Conferences

Abivax, a biotechnology company specializing in chronic inflammatory disease therapeutics, has announced its participation in several fall investor conferences. The company, listed on both Euronext Paris and Nasdaq, will engage in key discussions from November 9 to December 3, 2026, across the United States and Europe.

Notably, Abivax will feature in the Guggenheim Healthcare Innovation Conference in Boston, followed by the LifeSci Capital X Sofinnova Growth & Innovation Summit in London. The company will continue its presence at the German Equity Forum in Frankfurt and conclude this round of conferences at the Evercore ISI Annual Healthcare Conference in Miami and the Piper Sandler Healthcare Conference in New York.

Webcast links for some presentations will be accessible via Abivax's website for a short period post-conferences.